160 related articles for article (PubMed ID: 15117961)
1. Nestin is a potential mediator of malignancy in human neuroblastoma cells.
Thomas SK; Messam CA; Spengler BA; Biedler JL; Ross RA
J Biol Chem; 2004 Jul; 279(27):27994-9. PubMed ID: 15117961
[TBL] [Abstract][Full Text] [Related]
2. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
Li J; Kretzner L
Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
[TBL] [Abstract][Full Text] [Related]
5. Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors.
Krupkova O; Loja T; Redova M; Neradil J; Zitterbart K; Sterba J; Veselska R
Tumour Biol; 2011 Aug; 32(4):631-9. PubMed ID: 21340483
[TBL] [Abstract][Full Text] [Related]
6. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
Ross RA; Lazarova DL; Manley GT; Smitt PS; Spengler BA; Posner JB; Biedler JL
Eur J Cancer; 1997 Oct; 33(12):2071-4. PubMed ID: 9516855
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
8. N-myc modulates expression of p73 in neuroblastoma.
Zhu X; Wimmer K; Kuick R; Lamb BJ; Motyka S; Jasty R; Castle VP; Hanash SM
Neoplasia; 2002; 4(5):432-9. PubMed ID: 12192602
[TBL] [Abstract][Full Text] [Related]
9. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
10. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
12. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
13. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
14. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
15. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
17. Binding of a 40-kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-myc expression in human neuroblastoma.
Chagnovich D; Cohn SL
J Biol Chem; 1996 Dec; 271(52):33580-6. PubMed ID: 8969225
[TBL] [Abstract][Full Text] [Related]
18. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression.
Zaizen Y; Taniguchi S; Suita S
J Pediatr Surg; 1998 Dec; 33(12):1765-70. PubMed ID: 9869047
[TBL] [Abstract][Full Text] [Related]
19. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA.
Kabilova TO; Chernolovskaya EL; Vladimirova AV; Vlassov VV
Oligonucleotides; 2006; 16(1):15-25. PubMed ID: 16584292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]